Karl Chalabala
Stock Analyst at UBS
(0.93)
# 3,594
Out of 4,786 analysts
8
Total ratings
25%
Success rate
-6.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Karl Chalabala
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
FOLD Amicus Therapeutics | Maintains: Buy | $19 → $21 | $8.43 | +149.11% | 5 | Nov 7, 2024 | |
SCCO Southern Copper | Maintains: Sell | $47 → $50 | $94.14 | -47.37% | 1 | Feb 23, 2023 | |
CRK Comstock Resources | Maintains: Buy | $14 → $12 | $19.84 | -39.52% | 1 | Aug 14, 2017 | |
GPOR Gulfport Energy | Maintains: Buy | $21 → $18 | $183.13 | -90.17% | 1 | Aug 14, 2017 |
Amicus Therapeutics
Nov 7, 2024
Maintains: Buy
Price Target: $19 → $21
Current: $8.43
Upside: +149.11%
Southern Copper
Feb 23, 2023
Maintains: Sell
Price Target: $47 → $50
Current: $94.14
Upside: -47.37%
Comstock Resources
Aug 14, 2017
Maintains: Buy
Price Target: $14 → $12
Current: $19.84
Upside: -39.52%
Gulfport Energy
Aug 14, 2017
Maintains: Buy
Price Target: $21 → $18
Current: $183.13
Upside: -90.17%